Self-myofascial Release With Foam Roller in Patients With Hemophilic Knee Arthropathy
Haemophilia
About this trial
This is an interventional treatment trial for Haemophilia
Eligibility Criteria
Inclusion Criteria:
- Patients with a medical diagnosis of hemophilia A or B.
- Patients with a severe phenotype of hemophilia (<1% FVIII/FIX).
- Patients with a medical diagnosis of hemophilic knee arthropathy and more than 3 points on the Hemophilia Joint Health Score.
- Being over 18 years old.
- No scheduled orthopedic surgeries during the study phase
Exclusion Criteria:
- Patients with hemarthrosis in the month before the beginning of the study.
- Patients unable to walk.
- Severe functional alterations of the upper limb that prevented the exercises.
- Failure to sign the informed consent document
Sites / Locations
- University of Murcia
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Self-myofascial release
Control group
Each session will last approximately 15 minutes, with five physiotherapy sessions taking place over a period of 2 months. The Self-Myofascial release protocol for the lower limbs using a Foam Roller and and Solid Ball Massage, adapted to patients with hemophilic ankle arthropathy will include: Self-Myofascial release of the plantar region using and Solid Ball Massage; Release of the myofascial components of the back of the leg using a Foam Roller; Release of the myofascial components of the anterior part of the leg using a Foam Roller; Release of myofascial components of the hamstring region using a Foam Roller; Release of the myofascial components of the adductor muscles using a Solid Ball Massage in a sitting position; Release of the myofascial components of the abductor muscles using a Foam Roller in lateral decubitus; Release of the myofascial components of the pelvitrochanterian muscles using a Foam Roller in a sitting position.
The subjects included in the control group will not receive Physiotherapy sessions and will continue with their usual routine of activity and physical exercise, and with the same drug treatment schedule with FVIII / FIX and analgesic drugs.